Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes.

Clin Exp Immunol

St Vincent's Institute, The University of Melbourne, Department of Medicine, St Vincent's Hospital, Fitzroy, Vic, Australia.

Published: November 2010

Type 1 diabetes (T1D) is an autoimmune disease caused by the T cell-mediated destruction of the pancreatic insulin-producing beta cells. Currently there are no widely accepted and standardized assays available to analyse the function of autoreactive T cells involved in T1D. The development of such an assay would greatly aid efforts to understand the pathogenesis of T1D and is also urgently required to guide the development of antigen-based therapies intended to prevent, or cure, T1D. Here we describe some of the assays used currently to detect autoreactive T cells in human blood and review critically their strengths and weaknesses. The challenges and future prospects for the T cell assays are discussed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996587PMC
http://dx.doi.org/10.1111/j.1365-2249.2010.04237.xDOI Listing

Publication Analysis

Top Keywords

type diabetes
8
autoreactive cells
8
current approaches
4
approaches measuring
4
measuring human
4
human islet-antigen
4
islet-antigen specific
4
specific cell
4
cell function
4
function type
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!